Publications by authors named "Yulia Yu Scaffidi-Domianello"

Novel platinum complexes of trans geometry [PtCl(2){(Z)-R(H)C═NOH}(2)] [R = Me (1), Et (3)] and [PtCl(2){(E)-R(H)C═NOH}{(Z)-R(H)C═NOH}] [R = Me (2), Et (4)] as well as the classic trans-[PtCl(2)(R(2)C═NOH)(2)] [R = Me, Et] were reacted with an equivalent amount of silver acetate in acetone solution at ambient temperature, resulting in formation of unprecedented head-to-tail-oriented oximato-bridged dimers [PtCl{μ-(Z)-R(H)C═NO}{(Z)-R(H)C═NOH}](2) [R = Me (5), Et (7)], [PtCl{μ-(Z)-R(H)C═NO}{(E)-R(H)C═NOH}](2) [R = Me (6), Et (8)], and [PtCl(μ-R(2)C═NO)(R(2)C═NOH)](2) [R = Me (9), Et (10)], correspondingly. The dimeric species feature a unique six-membered diplatinacycle and represent the first example of oxime ligands coordinated to platinum via the oxygen atom. All complexes were characterized by elemental analyses, electrospray ionization mass spectrometry, IR and multinuclear ((1)H, (13)C, and (195)Pt) NMR spectroscopy, as well as X-ray diffraction in the cases of dimers 6 and 9.

View Article and Find Full Text PDF
Article Synopsis
  • Scientists are exploring new platinum complexes to overcome the side effects and resistance associated with the widely-used anticancer drug cisplatin.
  • Trans-configured platinum complexes with oxime ligands exhibit distinct properties, such as greater cellular accumulation and different DNA interaction patterns compared to cisplatin.
  • Studies demonstrate that these trans complexes are more effective at accumulating in cancer cells and causing DNA damage, indicating their potential as superior anticancer agents.
View Article and Find Full Text PDF

The reaction of 1,3-dihydroxyacetone oxime with diam(m)minediaquaplatinum(II) under basic conditions produced zwitterionic diam(m)mine(3-hydroxy-2-(oxidoimino)propan-1-olato-κ(2)N,O)platinum(II) complexes featuring the N,O-chelating ligand. Upon reaction with hydrochloric acid, it was possible to isolate either the singly protonated species still exhibiting the intact N,O-chelate or the open-chain chlorido complex. All complexes were characterized in detail with multinuclear ((1)H, (13)C, and (195)Pt) NMR spectroscopy, ESI mass spectrometry, and in one case X-ray diffraction.

View Article and Find Full Text PDF
Article Synopsis
  • A new series of bis(oxime)platinum(II) complexes with cis and trans configurations were created and analyzed using various scientific methods, including elemental analysis and NMR spectroscopy.
  • These complexes were evaluated for their cancer-fighting abilities in both cisplatin-sensitive and resistant cell lines, showing that all tested compounds can effectively combat cisplatin resistance.
  • Notably, the trans-configured complexes demonstrated significantly higher cytotoxicity, being as effective as cisplatin in sensitive cells and up to 20 times more effective in resistant cells.
View Article and Find Full Text PDF

The (benzophenone imine)platinum(II) compounds trans-[PtCl2(Ph2C=NH)(RR'SO)] [R, R'=Me, Me (2); n-Pr, n-Pr (3); (CH2)4 (4); Me, Ph (5); Me, p-MeC6H4 (6)] were prepared by the reaction of Ph2C=NH with K[PtCl3(RR'SO)], obtained in situ from K2[PtCl4] and the corresponding sulfoxide, giving 2-6 as well as cis-[PtCl2(Ph2C=NH)2] (1) as a minor product. The complexes were characterized by 1H, 13C, and 195Pt NMR and IR spectroscopy, electrospray ionization mass spectrometry, and C, H, and N elemental analysis. The X-ray crystallography of 1 enables confirmation of the cis configuration of the complex, while in 2 and 4.

View Article and Find Full Text PDF